Jaguar Health (JAGX) Raw Materials (2018 - 2026)
Jaguar Health (JAGX) posted quarterly Raw Materials of $4.9 million for Q1 2026, up 160.82% year-over-year from $1.9 million in Q1 2025, and up 140.37% quarter-over-quarter from $2.0 million in Q4 2025.
Jaguar Health (JAGX) Raw Materials (2018 - 2026) Analysis & Trends
Jaguar Health (JAGX) has reported Raw Materials for 9 consecutive years, with $4.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Raw Materials rose 160.82% year-over-year to $4.9 million; the TTM figure through Mar 2026 stood at $4.9 million (up 160.82% YoY), while the FY2025 annual figure was $2.0 million, up 10.32% from the prior year.
- Raw Materials advanced to $4.9 million in Q1 2026 per JAGX's latest filing, from $2.0 million in the prior quarter.
- Across five years, Raw Materials topped out at $4.9 million in Q1 2026 and bottomed at $1.6 million in Q1 2022.
- Historically, Raw Materials has averaged $2.1 million across 5 years, with a median of $2.0 million in 2025.
- Annual changes were most pronounced in 2022 — Raw Materials soared 178.46% — and 2025, when it slipped 14.58%.
- Jaguar Health's Raw Materials stood at $2.1 million in 2022, then slipped by 2.09% to $2.1 million in 2023, then decreased by 10.06% to $1.8 million in 2024, then advanced by 10.32% to $2.0 million in 2025, then soared by 140.37% to $4.9 million in 2026.
- Business Quant data shows JAGX's Raw Materials at $4.9 million in Q1 2026, $2.0 million in Q4 2025, and $2.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.40 Bn | 131.54 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.13 Bn | 78.13 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.58 Bn | 60.40 Bn | 1.37 Bn |
| 4 | Moderna | 58.23 Bn | 53.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.18 Bn | 37.08 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.30 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.97 Bn | 9.58 Bn | 668.28 Mn |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - |
| 10 | Jaguar Health | 443,629.24 | -9.62 Mn | 19.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.91 Mn |
| Dec 31, 2025 | 2.04 Mn |
| Sep 30, 2025 | 1.99 Mn |
| Jun 30, 2025 | 1.93 Mn |
| Mar 31, 2025 | 1.88 Mn |
| Dec 31, 2024 | 1.85 Mn |
| Sep 30, 2024 | 1.90 Mn |
| Jun 30, 2024 | 1.96 Mn |
| Mar 31, 2024 | 2.20 Mn |
| Dec 31, 2023 | 2.06 Mn |
| Sep 30, 2023 | 1.86 Mn |
| Jun 30, 2023 | 2.00 Mn |
| Mar 31, 2023 | 2.13 Mn |
| Dec 31, 2022 | 2.10 Mn |
| Sep 30, 2022 | 2.01 Mn |
| Jun 30, 2022 | 1.95 Mn |
| Mar 31, 2022 | 1.56 Mn |
| Dec 31, 2021 | 1.25 Mn |
| Sep 30, 2021 | 1.21 Mn |
| Jun 30, 2021 | 701,000.00 |